Physician profile
Joanne Arduin
NPI 1114073020
$742.97
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $29.80 · 2023: $630 · 2024: $82.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $713.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $127.85 | 2022-2023 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $126.44 | 2023-2024 | |
| Abbvie INC. | $112.03 | 2023-2024 | |
| Lilly USA, LLC | $82.37 | 2023 | Mounjaro, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $68.17 | 2023 | Jardiance, Synjardy |
| Amgen INC. | $33.32 | 2023 | Repatha, Otezla |
| Cumberland Pharmaceuticals, INC. | $32.86 | 2023 | Kristalose |
| Glaxosmithkline, LLC. | $31.92 | 2022-2023 | Shingrix |
| Astrazeneca Pharmaceuticals Lp | $29.00 | 2023-2024 | Farxiga, Airsupra |
| Ibsa Pharma INC. | $25.75 | 2023 | Tirosint, Licart |
| Astellas Pharma US INC | $21.28 | 2023 | Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $21.02 | 2023 | |
| Xeris Pharmaceuticals, INC. | $18.15 | 2023 | Gvoke Hypopen |
| Takeda Pharmaceuticals U.S.A., INC. | $12.81 | 2023 | Gattex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanne Arduin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.